相似文献
1
Uses and limitations of artificial intelligence for oncology.
Cancer. 2024 Jun 15;130(12):2101-2107. doi: 10.1002/cncr.35307. Epub 2024 Mar 30.
2
Advancing the frontier of artificial intelligence on emerging technologies to redefine cancer diagnosis and care.
Comput Biol Med. 2025 Jun;191:110178. doi: 10.1016/j.compbiomed.2025.110178. Epub 2025 Apr 13.
3
Driving Knowledge to Action: Building a Better Future With Artificial Intelligence-Enabled Multidisciplinary Oncology.
Am Soc Clin Oncol Educ Book. 2025 Jun;45(3):e100048. doi: 10.1200/EDBK-25-100048. Epub 2025 May 2.
4
Artificial intelligence for clinical oncology.
Cancer Cell. 2021 Jul 12;39(7):916-927. doi: 10.1016/j.ccell.2021.04.002. Epub 2021 Apr 29.
5
Artificial intelligence in oncology: current applications and future perspectives.
Br J Cancer. 2022 Jan;126(1):4-9. doi: 10.1038/s41416-021-01633-1. Epub 2021 Nov 26.
6
Artificial intelligence in oncology: Path to implementation.
Cancer Med. 2021 Jun;10(12):4138-4149. doi: 10.1002/cam4.3935. Epub 2021 May 7.
7
Fairness of artificial intelligence in healthcare: review and recommendations.
Jpn J Radiol. 2024 Jan;42(1):3-15. doi: 10.1007/s11604-023-01474-3. Epub 2023 Aug 4.
8
Challenges and perspectives in use of artificial intelligence to support treatment recommendations in clinical oncology.
Cancer Med. 2024 Jun;13(12):e7398. doi: 10.1002/cam4.7398.
9
Consensus statements on the current landscape of artificial intelligence applications in endoscopy, addressing roadblocks, and advancing artificial intelligence in gastroenterology.
Gastrointest Endosc. 2025 Jan;101(1):2-9.e1. doi: 10.1016/j.gie.2023.12.003. Epub 2024 Apr 17.
10
Artificial Intelligence-Driven Radiomics in Head and Neck Cancer: Current Status and Future Prospects.
Int J Med Inform. 2024 Aug;188:105464. doi: 10.1016/j.ijmedinf.2024.105464. Epub 2024 Apr 23.
引用本文的文献
1
Systematic review of cost effectiveness and budget impact of artificial intelligence in healthcare.
NPJ Digit Med. 2025 Aug 26;8(1):548. doi: 10.1038/s41746-025-01722-y.
2
Towards machine learning fairness in classifying multicategory causes of deaths in colorectal or lung cancer patients.
Brief Bioinform. 2025 Jul 2;26(4). doi: 10.1093/bib/bbaf398.
3
Diagnostic, Therapeutic, and Prognostic Applications of Artificial Intelligence (AI) in the Clinical Management of Brain Metastases (BMs).
Brain Sci. 2025 Jul 8;15(7):730. doi: 10.3390/brainsci15070730.
4
AI-Powered Insights into Drug Resistance in Gastric Cancer: A Path Toward Precision Therapy.
Iran J Pharm Res. 2025 May 25;24(1):e159954. doi: 10.5812/ijpr-159954. eCollection 2025 Jan-Dec.
5
AI-powered advances in type II endometrial cancer: global trends and African contexts.
Front Oncol. 2025 Jul 9;15:1581645. doi: 10.3389/fonc.2025.1581645. eCollection 2025.
6
Large language model integrations in cancer decision-making: a systematic review and meta-analysis.
NPJ Digit Med. 2025 Jul 17;8(1):450. doi: 10.1038/s41746-025-01824-7.
7
Threefold IPSS-M reclassification outperforms original stratification in predicting post-transplant outcomes for MDS patients.
Cell Transplant. 2025 Jan-Dec;34:9636897251348406. doi: 10.1177/09636897251348406. Epub 2025 Jun 24.
8
The use of artificial intelligence in stereotactic ablative body radiotherapy for hepatocellular carcinoma.
Front Med (Lausanne). 2025 Jun 6;12:1576494. doi: 10.3389/fmed.2025.1576494. eCollection 2025.
9
From Development to Implementation: A Systematic Review on the Current Maturity Status of Artificial Intelligence Models for Patients with Colorectal Cancer Liver Metastases.
Oncology. 2025 May 26:1-10. doi: 10.1159/000546572.
10
Artificial intelligence in neuro-oncology: methodological bases, practical applications and ethical and regulatory issues.
Clin Transl Oncol. 2025 May 22. doi: 10.1007/s12094-025-03948-4.
本文引用的文献
1
Large Language Model-Based Chatbot vs Surgeon-Generated Informed Consent Documentation for Common Procedures.
JAMA Netw Open. 2023 Oct 2;6(10):e2336997. doi: 10.1001/jamanetworkopen.2023.36997.
2
Comparison of humans versus mobile phone-powered artificial intelligence for the diagnosis and management of pigmented skin cancer in secondary care: a multicentre, prospective, diagnostic, clinical trial.
Lancet Digit Health. 2023 Oct;5(10):e679-e691. doi: 10.1016/S2589-7500(23)00130-9.
3
Use of Artificial Intelligence Chatbots for Cancer Treatment Information.
JAMA Oncol. 2023 Oct 1;9(10):1459-1462. doi: 10.1001/jamaoncol.2023.2954.
4
Assessment of Artificial Intelligence Chatbot Responses to Top Searched Queries About Cancer.
JAMA Oncol. 2023 Oct 1;9(10):1437-1440. doi: 10.1001/jamaoncol.2023.2947.
5
Using measures of race to make clinical predictions: Decision making, patient health, and fairness.
Proc Natl Acad Sci U S A. 2023 Aug 29;120(35):e2303370120. doi: 10.1073/pnas.2303370120. Epub 2023 Aug 22.
6
Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study.
Lancet Oncol. 2023 Aug;24(8):936-944. doi: 10.1016/S1470-2045(23)00298-X.
7
The imperative for regulatory oversight of large language models (or generative AI) in healthcare.
NPJ Digit Med. 2023 Jul 6;6(1):120. doi: 10.1038/s41746-023-00873-0.
8
Racial and Ethnic Bias in Risk Prediction Models for Colorectal Cancer Recurrence When Race and Ethnicity Are Omitted as Predictors.
JAMA Netw Open. 2023 Jun 1;6(6):e2318495. doi: 10.1001/jamanetworkopen.2023.18495.
9
Multi-vendor evaluation of artificial intelligence as an independent reader for double reading in breast cancer screening on 275,900 mammograms.
BMC Cancer. 2023 May 19;23(1):460. doi: 10.1186/s12885-023-10890-7.
10
Large language models and the perils of their hallucinations.
Crit Care. 2023 Mar 21;27(1):120. doi: 10.1186/s13054-023-04393-x.
Zotero 插件